Francisella tularensis O-antigen

The **Francisella tularensis O-antigen** is a tetrasaccharide repeat polysaccharide that serves as a capsular polysaccharide and integral component of the lipopolysaccharide (LPS) in the Gram-negative bacterium Francisella tularensis[1][2][3][4][5]. As a major surface antigen, it plays a crucial role in bacterial virulence by promoting immune evasion, mediating resistance to complement-mediated bactericidal activity, and facilitating intracellular survival within host cells[2][3][5]. The O-antigen is a target for protective antibodies, and experimental monoclonal antibodies against internal O-antigen epitopes have demonstrated the ability to reduce bacterial burden and protect in animal models of tularemia[1]. Unlike other Gram-negative bacteria, F. tularensis LPS (including O-antigen) is poorly immunostimulatory, which contributes to delayed host immune response and severe infection[3][5]. The O-antigen, along with the associated capsular material, is being actively explored as a candidate for vaccine development and as a diagnostic marker, though challenges remain due to antigenic variation and immune evasion strategies[1][2][5]. Additional clarification: - The term **"Francisella tularensis antigen"** is not specific and may refer to various antigens (proteins, carbohydrates) produced by the bacterium; however, in scientific literature, **"O-antigen"** is the surface carbohydrate most frequently targeted by monoclonal antibodies and vaccine research[1][2]. It is not a receptor, enzyme, or protein, but rather a polysaccharide antigen, so this entry is technically not a conventional "therapeutic target" in the sense of a druggable protein or receptor, but it is a validated immunological target for antibodies and vaccines[1][2]. - There is **no standard abbreviation** used in the literature other than "O-antigen" or "OAg." - If the query intends a protein target rather than a carbohydrate antigen, further specificity is required.

Other names

O-antigen of Francisella tularensisFrancisella tularensis lipopolysaccharide O-antigenFt OAg

Induction of protective antibody-mediated immunity; experimental monoclonal antibodies inhibit infection by binding and neutralizing O-antigen[1]